Trial intelligence / Profile preview

Preoperative pregabalin 150 mg versus 300 mg in total hip arthroplasty

PACTR202201644616894Phase 0Not yet recruiting

Sponsor
Mansoura University
Start
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 0, randomised trial of pregabalin in postoperative pain (3 arms), sponsored by Mansoura University. Primary endpoints: Duration of sensory block and Duration of motor block. Planned start Mar 2022; status: not yet recruiting.

02

Drugs

pregabalin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR202201644616894.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202201644616894.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call